Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExPERT study of morning versus evening amlodipine + valsartan in uncontrolled essential hypertension
2006-006719-66Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amlodipine and valsartan in essential hypertension (2 arms), sponsored by Novartis. Primary endpoint: Change from V2 to V4 in 24-hour mean ambulatory systolic blood pressure. Started May 2007; status: completed.
02
Drugs
amlodipinevalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-006719-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006719-66.